Opening keynote: Opportunities & challenges faced for biotech’s in 2025
02 Sep 2025
Pau Casals
Investment Summit
- How the biotech market has shifted since its valuation peak of 2021-22
- Why early-stage ATMP innovation still holds promise
- Regional hotspots, cautious optimism, and where risk capital is heading